Alvaro Luiz Bertho | Immunology & Serology | Best Researcher Award

Prof. Dr. Alvaro Luiz Bertho | Immunology & Serology | Best Researcher Award

Principal Investigator at Oswaldo Cruz Institute, FIOCRUZ, Brazil

Dr. Alvaro Luiz Bertho dos Santos is a renowned biomedical scientist recognized for groundbreaking contributions in immunology, immunoparasitology, and flow cytometry. Based at a leading public health research institute, he leads efforts that bridge cellular biology with infectious disease research. As director of a high-impact flow cytometry facility, he facilitates cutting-edge analysis and mentorship within the scientific community. Dr. Bertho is widely respected for pioneering the use of flow cytometry in his region and for his role in shaping future generations of researchers through graduate-level teaching. He actively contributes to international scientific societies, serves as a peer reviewer, and champions global collaboration. His scholarship includes numerous peer-reviewed articles, book chapters, and technical guides. With a career dedicated to research excellence, infrastructure development, and public health impact, he has earned a distinguished reputation and consistently drives innovation in immunoparasitology and cellular immunology.

Professional Profile

  Google Scholar | ORCID  profile  

Education

Dr. Bertho possesses a robust academic foundation in biomedical sciences and public health. His educational pathway included intensive training in immunology, parasitology, and cellular biology at preeminent institutions in Brazil. Throughout his studies, he honed advanced laboratory skills, experimented with cutting-edge analytical instruments, and developed strong theoretical understanding of disease immunopathogenesis. His graduate research focused on immune cell behavior during parasitic infections, integrating experimental methods with theoretical frameworks. This educational background equipped him with the knowledge to design impactful studies on host–pathogen interactions and cellular immune responses. It also prepared him to lead high-level scientific facility operations and to guide emerging scholars. His academic credentials reflect a blend of rigorous coursework, practical laboratory training, and collaborative research exposure—creating a foundation for his lifelong contributions to the biomedical and public health research community.

Experience

Dr. Bertho is a seasoned researcher who leads public health–oriented investigations into infectious diseases. As head of a premier flow cytometry facility, he manages complex analyses and supports multiple research collaborations. He mentors graduate students within a parasite biology research program, guiding thesis design, technical execution, and scientific dissemination. His experience spans research coordination, laboratory leadership, and interdisciplinary projects involving cellular immunology and infectious disease pathology. In academic settings, he has contributed to undergraduate and graduate teaching and provided specialized consulting on immunology topics. In previous roles, he has advised clinical laboratories and taught in complementary biomedical programs, combining practical diagnostics expertise with academic instruction. His professional experience embodies leadership, technical innovation, and mentorship in research-intensive environments.

Award and Honor

While specific prize names are not listed, Dr. Bertho’s career is marked by significant recognition within national and international scientific communities. He is a respected member of multiple scientific associations dedicated to cytometry and extracellular vesicle research, as well as regional immunology organizations. His reputation as a leader in flow cytometry and infectious disease immunology is underlined by frequent invitations to peer-review leading international journals. He is known for developing institutional platforms and technical manuals that support both education and research, contributing to research infrastructure recognized across the region. His professional standing reflects community acknowledgment of his scientific contributions, thought leadership, and service to the research community. The honors implicit in his leadership roles and institutional impact reinforce his status as an esteemed researcher.

Research Focus

Dr. Bertho’s research explores immune mechanisms in parasitic and infectious diseases, with a special focus on immune cell–derived extracellular vesicles. He investigates how these vesicles influence disease onset, progression, and immune regulation, particularly in tropical diseases like malaria and leishmaniasis. His work leverages advanced flow cytometry techniques to uncover biomarkers and cellular pathways involved in host–pathogen interactions. By combining immunogenetic analysis, cell biology, and technology-driven profiling tools, he aims to understand how immune dysregulation contributes to disease severity. His research supports development of targeted diagnostics and therapeutic strategies, and contributes to vaccine-related investigations through detailed immune profiling. Dr. Bertho’s focus emphasizes translational potential, linking basic science to public health outcomes and fostering collaborative frameworks across research networks.

Research Skill

Dr. Bertho brings a highly specialized skill set in flow cytometry, immunoanalytical assays, and molecular immunology. He excels in experimental design for immune profiling, extracellular vesicle characterization, and immunogenetics studies. As a facility director, he oversees instrumentation management, protocol development, and multidisciplinary support for internal and external collaborators. He also excels in academic mentorship, guiding complex research projects and fostering critical thinking among students. His communication skills include authoring scientific papers, technical manuals, and teaching curricula. He is adept at coordinating research grants, network collaborations, and peer-review processes. His skill set also includes consulting on immunology methodologies and supporting large research infrastructures. These competencies position him as a key leader in immunoparasitology research, educational mentorship, and infrastructure development.

Publication Top Notes

Title: Identification of naturally infected Lutzomyia intermedia and Lutzomyia migonei with Leishmania (Viannia) braziliensis in Rio de Janeiro (Brazil) revealed by a polymerase chain reaction assay
Transactions of the Royal Society of Tropical Medicine and Hygiene
Citations: 210
Year: 2005

Title: Leishmania-reactive CD4⁺ and CD8⁺ T cells associated with cure of human cutaneous leishmaniasis
Infection and Immunity
Citations: 170
Year: 1994

Title: Synthesis, pharmacological evaluation and electrochemical studies of novel 6-nitro-3,4-methylenedioxyphenyl-N-acylhydrazone derivatives: Discovery of LASSBio-881, a new ligand for neuropathic and inflammatory pain
Bioorganic & Medicinal Chemistry
Citations: 107
Year: 2007

Title: Evaluation of the stability and immunogenicity of autoclaved and nonautoclaved preparations of a vaccine against American tegumentary leishmaniasis
Citations: 102
Year: 1999

Tile: T-cell responsiveness of American cutaneous leishmaniasis patients to purified Leishmania pifanoi amastigote antigens and Leishmania braziliensis promastigote antigens: Immunologic patterns associated with cure
Experimental Parasitology
Citations: 101
Year: 1996

Title: Characterization of human T lymphocyte-mediated immune responses induced by a vaccine against American tegumentary leishmaniasis
The American Journal of Tropical Medicine and Hygiene
Citations: 93
Year: 1995

Title: Flow cytometry in the study of cell death
Memórias do Instituto Oswaldo Cruz
Citations: 92
Year: 2000

Title: Leishmania amazonensis: Multidrug resistance in vinblastine-resistant promastigotes is associated with rhodamine 123 efflux, DNA amplification, and RNA overexpression of a P-glycoprotein gene
Experimental Parasitology
Citations: 80
Year: 1995

Title: Immunologic patterns associated with cure in human American cutaneous leishmaniasis
Brazilian Journal of Medical and Biological Research
Citations: 68
Year: 1998

Title: Flow cytometric analysis of cellular infiltrate from American tegumentary leishmaniasis lesions
British Journal of Dermatology
Citations: 67
Year: 2005

Title: Detection of early apoptosis and cell death in CD4⁺ and CD8⁺ T cells from lesions of patients with localized cutaneous leishmaniasis
Brazilian Journal of Medical and Biological Research
Citations: 57
Year: 2000

Conclusion

Dr. Alvaro Luiz Bertho dos Santos stands out as a distinguished and pioneering researcher whose long-standing contributions to immunoparasitology and flow cytometry have had a transformative effect on biomedical research in Brazil and Latin America. His prolific scientific output, leadership in research infrastructure, commitment to mentorship, and active role in international scientific societies make him highly deserving of the Best Researcher Award. With continued focus on global engagement and scholarly visibility, Dr. Bertho is well-positioned to lead future advancements in infectious disease research and contribute meaningfully to global health challenges.

Wenqing Li | Immunology & Serology | Best Researcher Award

Prof. Dr. Wenqing Li | Immunology & Serology | Best Researcher Award 

Professor at Nantong University School of Medicine, China

Professor Wenqing Li is a distinguished scientist in the field of biomedical science, currently serving as a professor at the School of Medicine, Nantong University. He holds a B.S. in Biological Sciences from Anhui Normal University (2009) and a Ph.D. in Cell Biology from the University of Science and Technology of China (2014). His postdoctoral training was conducted at The Pennsylvania State University (2014–2016), followed by a research position at The Ohio State University (2016–2020). Since 2020, he has led an innovative research program at Nantong University, contributing significantly to the fields of nanomedicine, cancer immunotherapy, and male reproductive health.

profile

scopus

Education

Dr. Li’s academic journey is rooted in top-tier Chinese and American institutions. He began with a Bachelor’s degree in Biological Sciences at Anhui Normal University, developing a strong foundation in molecular biology. His passion for advanced cellular mechanisms led him to pursue a Ph.D. in Cell Biology at the prestigious University of Science and Technology of China, where he cultivated expertise in nanobiotechnology. Further enhancing his academic experience, he undertook rigorous postdoctoral research at The Pennsylvania State University, followed by a role as assistant researcher at The Ohio State University. These global experiences shaped his multidisciplinary approach to research in biomedicine.

Experience

Dr. Li’s professional experience spans academia and international research environments. His early postdoctoral work at Penn State focused on nanomaterials and bio-conjugates. At Ohio State, he contributed to translational nanomedicine, developing innovative drug delivery systems. His current role as professor at Nantong University involves supervising research in lipid nanoparticle-based therapeutics, immunotherapy, and reproductive biology. A recognized research leader, he is also a key member of the Jiangsu Provincial Outstanding Scientific and Technological Innovation Team for Male Reproductive Health and has successfully secured and led major grants from the National Natural Science Foundation of China.

Research Interest

Professor Li’s research interests lie at the intersection of nanotechnology, molecular biology, and immunotherapy. His current work centers on the development of lipid nanoparticles for mRNA delivery and cancer immunotherapy, including platforms co-delivering STING agonists and mRNA to synergize antitumor responses. He also investigates lipid nanoparticle applications in restoring spermatogenesis in infertile males and treats Non-Obstructive Azoospermia (NOA). His broad interests also include nanotoxicology and male contraceptive development using functionalized nanomaterials. His translational research has bridged fundamental science with therapeutic innovations.

Award

Professor Li was honored with the Jiangsu Distinguished Professor Award in 2020 in recognition of his contributions to biomedical science and innovation. He was also the recipient of funding from the National Natural Science Foundation of China (Youth Program) between 2016 and 2018 for his work on the reproductive toxicity of gold nanoparticles. His innovative research and leadership in translational nanomedicine have garnered national attention, positioning him as a strong contender for the Best Researcher Award.

Publication

Among his numerous high-impact publications, seven notable articles include:

“Vitamin lipid nanoparticles enable adoptive macrophage transfer for the treatment of multidrug-resistant bacterial sepsis” published in Nature Nanotechnology (2020), cited 226 times.

“Functionalized lipid-like nanoparticles for in vivo mRNA delivery and base editing” published in Science Advances (2020), cited 144 times.

“Leveraging mRNA Sequences and Nanoparticles to Deliver SARS-CoV-2 Antigens In Vivo” in Advanced Materials (2020), cited 106 times.

“Biomimetic nanoparticles deliver mRNAs encoding costimulatory receptors and enhance T cell mediated cancer immunotherapy” in Nature Communications (2021), cited 82 times.

“Ratiometric fluorescent probes for capturing endogenous hypochlorous acid in the lungs of mice” in Chemical Science (2018), cited 99 times.

“Long-term storage of lipid-like nanoparticles for mRNA delivery” in Bioactive Materials (2020), cited 183 times.

“Amplifying the Antitumor Effect of STING Agonist MSA-2 by Phospholipid Nanoparticles Delivering STING mRNA and Copper-Modified MSA-2 Combination” in ACS Applied Materials & Interfaces (2025), early-stage with growing recognition.
These publications have significantly influenced nanomedicine, genome editing, and therapeutic delivery systems.

Conclusion

In conclusion, Dr. Wenqing Li exemplifies the qualities of an outstanding researcher. His academic rigor, innovation in lipid-based nanotechnology, impactful publications, and translational focus collectively position him as a leading figure in biomedical science. His contributions not only push the boundaries of current knowledge but also pave the way for novel therapeutic approaches. Therefore, it is with strong confidence that Dr. Wenqing Li is recommended as a highly deserving recipient of the Best Researcher Award.